Whitepaper (DE / EN)
Leadership on Demand in Times of Disruption
Why experienced interim executives make radical innovation effective in MedTech & Life Sciences— when organizations must deliver stability while renewing themselves radically.
Executive Summary
From 2026 onwards, MedTech and Life Sciences are reshaped not incrementally, but in leaps—driven by regulation, cost pressure, digital health, platform economics, data-driven medicine, AI, and new care models. Many organizations respond with evolutionary improvements, which can create medium-term strategic risk: overengineering, margin erosion, and commoditization. Disruption often emerges outside the industry along new value chains—and unfolds faster than ever. In this environment, Leadership on Demand gains strategic relevance: experienced interim executives create impact where stability in the core business and radical renewal must happen in parallel.
Why disruption especially affects MedTech & Life Sciences
- Multiple forces from 2026+: regulation, cost pressure, digital health, platform economics, AI and new care models act simultaneously.
- Disruption often comes from outside: non-industry players and new value chains reshape expectations and competitive logics.
- Speed increases: change unfolds faster than in earlier market phases.
- Regulated markets aren’t slow—they’re complex: innovation needs governance and execution discipline, not only ideas.
Evolutionary vs. radical: the decisive distinction
- Evolutionary innovation optimizes existing products and processes (more functionality, higher performance, more variants) in established markets.
- Radical innovation creates new categories, business models or value creation—radical (radix) means at the root: organizational development.
- Key point: radical innovation rarely fails due to missing ideas, but due to missing governance, prioritization and execution.
The overengineering trap
- Rising portfolio complexity and variant proliferation
- Higher cost structures and longer development cycles
- Lower willingness to pay: value does not increase proportionally
- Result: margin pressure and commoditization, markets drift into phase 4 (price)
When Leadership on Demand is the right lever
- Key leadership vacancies: safeguarding continuity and pace in critical roles.
- Transformation & change: high complexity with tight time windows.
- Scaling: building structures, teams and operating cadence alongside growth.
- PMI / carve-outs: ensuring governance and alignment during transitions.
- Commercial acceleration: focus, cadence and execution power in go-to-market excellence.
How fast impact is created
In disruptive phases, interim executives are not “gap fillers.” They act as impact accelerators: they stabilize, prioritize, decide, communicate and execute consistently—even under uncertainty and incomplete data. Especially in radical innovation, one insight becomes clear: the bottleneck is rarely technology. The bottleneck is leadership.
Conclusion
Disruption is not optional; it is reality. In MedTech & Life Sciences, it is no longer enough to become “better”, companies must become different. Leadership on Demand is a strategic lever to safeguard stability in the core business while making radical innovation deliverable; through governance, focus and execution power.
Disclaimer: This document is for general informational purposes only and does not constitute a binding offer. All information is provided without liability.